ReviewEuropean heart journal2026
Cardiac endogenous transmitter system: molecular features, functions, and clinical implications.
Review in European heart journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Trial
- Neural Regulation of Cardiac Arrhythmias: From the Brain-Heart Axis to Emerging Precision Therapies.Research (Washington, D.C.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Transmitter systems are molecular networks that facilitate signal transmission between neurons or between neurons and effector cells. Well-established examples include the glutamatergic, cholinergic, GABAergic, dopaminergic, serotonergic, and histaminergic systems. Traditionally, the heart was thought to lack its own endogenous transmitter systems (ETSs). However, recent studies have identified several such systems within cardiomyocytes and cardiac pacemaker cells. This review focuses on the endogenous glutamatergic, cholinergic, and GABAergic systems in the heart, providing a comprehensive analysis of their molecular composition, electrophysiological functions, arrhythmogenic implications, and therapeutic potential. Based on these findings, this review proposes a transmitter-based model of cardiac bioelectric regulation and highlights innovative strategies for targeting ETSs to prevent and treat arrhythmias.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.